Anika Therapeutics reported $6.53M in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 1189M 604M
Acceleron Pharma XLRN:US $ -63.52M 0.05M
Agenus AGEN:US $ -83.29M 29.61M
Agios Pharmaceuticals AGIO:US $ -86.22M 1960.54M
Anika Therapeutics ANIK:US $ 6.53M 3.69M
Arrowhead Research ARWR:US $ -29924000 3.11M
Chemocentryx CCXI:US $ -39.21M 9.5M
Dicerna Pharmaceuticals DRNA:US $ -40.82M 10.85M
Flexion Therapeutics FLXN:US $ -22208000 6.35M
Halozyme Therapeutics HALO:US $ 91.46M 63.56M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Immunogen IMGN:US $ -30.74M 3.31M
Insmed INSM:US $ -117321000 25.68M
Integra Lifesciences IART:US $ 35.07M 10.33M
Johnson & Johnson JNJ:US $ 6278M 81M
Karyopharm Therapeutics KPTI:US $ -53582000 3.83M
Ligand Pharmaceuticals LGND:US $ 30.72M 12.62M
Macrogenics MGNX:US $ -39.94M 11.34M
Merit Medical Systems MMSI:US $ 4.92M 6.04M
Peregrine Pharmaceuticals PPHM:US $ 6.3M 4.31M
Rigel Pharmaceuticals RIGL:US $ -13.82M 53.32M
Sangamo Biosciences SGMO:US $ -47.17M 1.24M
Stryker SYK:US $ 592M 290M
Surmodics SRDX:US $ -3.29M 11.37M
Veracyte VCYT:US $ -9.04M 32.83M
Xencor XNCR:US $ 52.25M 54.74M
Zimmer Biomet Holdings Inc ZBH:US $ 141.9M 56.2M